Rhabdomyolysis and Neuroleptic Malignant Syndrome Associated with Very Low-dose Antipsychotics in Children and Adolescent
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Along with the field of adult psychiatry, antipsychotic agents are increasingly used in the field of child and adolescent psychiatry. Although neuroleptic malignant syndrome (NMS) and rhabdomyolysis are rare complication associated with antipsychotic agent, clinicians should need to pay attention to all potential adverse drug reaction (ADR). Also, ADRs in child and adolescent could show different signs and symptoms compared with those in adult. In this case report, we present a case of NMS in a child which occurred shortly after the resolution of rhabdomyolysis which was induced by low-dose risperidone.
Abstract
Along with the field of adult psychiatry, antipsychotic agents are increasingly used in the field of child and adolescent psychiatry. Although neuroleptic malignant syndrome (NMS) and rhabdomyolysis are rare complication associated with antipsychotic agent, clinicians should need to pay attention to all potential adverse drug reaction (ADR). Also, ADRs in child and adolescent could show different signs and symptoms compared with those in adult. In this case report, we present a case of NMS in a child which occurred shortly after the resolution of rhabdomyolysis which was induced by low-dose risperidone.
참고문헌 (10)
- Kim BN, "The clinical use of risperidone in child & adolescent psychiatry", Clin Psychopharmacol Neurosci, 1(Suppl), pp.178~187 (2003)
- Star K, "Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines : a case series analysis", J Child Adolesc Psychopharmacol, 22, pp.440~451 (2012)
- Rani FA, "Paediatric atypical antipsychotic monitoring safety(PAMS)study : pilot study in children and adolescents in secondary-and tertiary-care settings", Drug Saf, 32, pp.325~333 (2009)
- Yeon-Woo Lee, "Subjective Well-being in Patients with Schizophrenia Treated with Atypical Antipsychotics: The Impact of Psychopathology and Adverse Drug Effects", Clinical Psychopharmacology and Neuroscience, 8(3), pp.149~155 (2010), 대한정신약물학회
- Shalev A, "Mortality from neuroleptic malignant syndrome", J Clin Psychiatry, 50, pp.18~25 (1989)
- Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
- Gurrera RJ, "Meta-analytic evidence of systematic bias in estimates of neuroleptic malignant syndrome incidence", Compr Psychiatry, 48, pp.205~211 (2007)
- Zito JM, "Psychotropic practice patterns for youth : a 10-year perspective", Arch Pediatr Adolesc Med, 157, pp.17~25 (2003)
- Mannix R, "Acute pediatric rhabdomyolysis : causes and rates of renal failure", Pediatrics, 118, pp.2119~2125 (2006)
- Neuhut R, "Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication : a review", J Child Adolesc Psychopharmacol, 19, pp.415~422 (2009)